Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells

• Jing Zhang,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Visualization, Writing – original draft

  Affiliation Department of Mechanical Engineering, University of Connecticut, Storrs, Connecticut, United States of America

  ⨯
• Sasia-Marie Jones,

  Roles Data curation, Resources

  Affiliation New England Sickle Cell Institute, Division of Hematology-Oncology, Neag Comprehensive Cancer Center, UCONN Health, University of Connecticut, Farmington, Connecticut, United States of America

  ⨯
• George Lykotrafitis ,

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft

  * E-mail: george.lykotrafitis@uconn.edu (GL); andemariam@uchc.edu (BA)

  Affiliations Department of Mechanical Engineering, University of Connecticut, Storrs, Connecticut, United States of America, Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut, United States of America

  http://orcid.org/0000-0003-2088-5478

  ⨯
• Biree Andemariam

  Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Writing – original draft

  * E-mail: george.lykotrafitis@uconn.edu (GL); andemariam@uchc.edu (BA)

  Affiliation New England Sickle Cell Institute, Division of Hematology-Oncology, Neag Comprehensive Cancer Center, UCONN Health, University of Connecticut, Farmington, Connecticut, United States of America

  ⨯